(Q48096370)

8 February 2018

title

Overlapping expression of serotonin transporters and neurokinin-1 receptors in posttraumatic stress disorder: a multi-tracer PET study (English)

1 reference

8 February 2018

author

Andreas Frick

1

1 reference

8 February 2018

Fredrik Ahs

2

1 reference

8 February 2018

Tomas Furmark

11

object named as

T Furmark

1 reference

8 February 2018

13

M Fredrikson

1 reference

8 February 2018

Å M Palmquist

3

1 reference

8 February 2018

A Pissiota

4

1 reference

8 February 2018

U Wallenquist

5

1 reference

8 February 2018

M Fernandez

6

1 reference

8 February 2018

M Jonasson

7

1 reference

8 February 2018

L Appel

8

1 reference

8 February 2018

Ö Frans

9

1 reference

8 February 2018

M Lubberink

10

1 reference

8 February 2018

L von Knorring

12

1 reference

8 February 2018

language of work or name

English

0 references

publication date

1 December 2015

1 reference

8 February 2018

published in

Molecular Psychiatry

1 reference

8 February 2018

volume

21

1 reference

8 February 2018

issue

10

1 reference

8 February 2018

page(s)

1400-1407

1 reference

8 February 2018

Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Longitudinal course of posttraumatic stress disorder and posttraumatic stress disorder symptoms in a community sample of adolescents and young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Psychiatric comorbidity of full and partial posttraumatic stress disorder among older adults in the United States: results from wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Recent progress in understanding the pathophysiology of post-traumatic stress disorder: implications for targeted pharmacological treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Biological studies of post-traumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Psychophysiologic assessment of aversive conditioning in posttraumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

In search of the trauma memory: a meta-analysis of functional neuroimaging studies of symptom provocation in posttraumatic stress disorder (PTSD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Human fear conditioning and extinction in neuroimaging: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Human 5-HT transporter availability predicts amygdala reactivity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Reduced amygdala serotonin transporter binding in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

The 5-HTTLPR polymorphism and posttraumatic stress disorder: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Human fear conditioning is related to dopaminergic and serotonergic biological markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Chronic antidepressant treatment impairs the acquisition of fear extinction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress disorder and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Mammalian Tachykinin Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

An unidentified depressor substance in certain tissue extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Neuroanatomical localisation of Substance P in the CNS and sensory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

The role of substance P in stress and anxiety responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Decreased neurokinin-1 (substance P) receptor binding in patients with panic disorder: positron emission tomographic study with [18F]SPA-RQ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Symptom provocation in specific phobia affects the substance P neurokinin-1 receptor system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Anxiolytic-like effects of the neurokinin 1 receptor antagonist GR-205171 in the elevated plus maze and contextual fear-potentiated startle model of anxiety in gerbils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Effects of substance P in the amygdala, ventromedial hypothalamus, and periaqueductal gray on fear-potentiated startle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

The neurokinin-1 receptor antagonist aprepitant in co-morbid alcohol dependence and posttraumatic stress disorder: a human experimental study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Emotional processing in anterior cingulate and medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Ventromedial prefrontal cortex is critical for the regulation of amygdala activity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Reduction of substance P after chronic antidepressants treatment in the striatum, substantia nigra and amygdala of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Mapping neurotransmitter networks with PET: an example on serotonin and opioid systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Distribution volume ratios without blood sampling from graphical analysis of PET data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Consensus nomenclature for in vivo imaging of reversibly binding radioligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Visualization and quantification of neurokinin-1 (NK1) receptors in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

MR-based automatic delineation of volumes of interest in human brain PET images using probability maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

The effect of early trauma exposure on serotonin type 1B receptor expression revealed by reduced selective radioligand binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

The neurocircuitry of fear, stress, and anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Higher in vivo serotonin-1a binding in posttraumatic stress disorder: a PET study with [11C]WAY-100635

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Age, sex and NK1 receptors in the human brain -- a positron emission tomography study with [¹¹C]GR205171.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Gender and age affect NK1 receptors in the human brain - a positron emission tomography study with [18F]SPA-RQ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Association of posttraumatic stress disorder with reduced in vivo norepinephrine transporter availability in the locus coeruleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Serotonin Synthesis and Reuptake in Social Anxiety Disorder: A Positron Emission Tomography Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Differences in Anxiety-Like Behavior within a Batch of Wistar Rats Are Associated with Differences in Serotonergic Transmission, Enhanced by Acute SRI Administration, and Abolished By Serotonin Depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Corticotropin-releasing factor mRNA and substance P receptor binding in the paraventricular hypothalamic nucleus, central nucleus of the amygdala, and locus coeruleus of Sprague-Dawley rats following restraint-induced stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Effects of substance P and Sar-Met-SP, a NK1 agonist, in distinct amygdaloid nuclei on anxiety-like behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Anxiety-like behavior is modulated by a discrete subpopulation of interneurons in the basolateral amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Substance P stimulates inhibitory synaptic transmission in the guinea pig basolateral amygdala in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Increased neurokinin-1 receptor availability in the amygdala in social anxiety disorder: a positron emission tomography study with [11C]GR205171.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Results from 2 randomized, double-blind, placebo-controlled studies of the novel NK1 receptor antagonist casopitant in patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

The development of a Clinician-Administered PTSD Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.180

Human serotonin transporter availability predicts fear conditioning

21 January 2018

1 reference

12 December 2020

Substance P is involved in terminating the hypothalamo- pituitary-adrenal axis response to acute stress through centrally located neurokinin-1 receptors

1 reference

12 December 2020

Brain uptake and receptor binding of two [11C]labelled selective high affinity NK1-antagonists, GR203040 and GR205171--PET studies in rhesus monkey

1 reference

12 December 2020

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

1 reference

12 December 2020

The psychophysiology of posttraumatic stress disorder: a meta-analysis

1 reference

12 December 2020

Evidence for the differential co-localization of neurokinin-1 receptors with 5-HT receptor subtypes in rat forebrain

1 reference

12 December 2020

Serotonin and substance P co-exist in dorsal raphe neurons of the human brain

1 reference

12 December 2020

The development of a Clinician-Administered PTSD Scale

1 reference

12 December 2020

Imaging the serotonin transporter during major depressive disorder and antidepressant treatment

1 reference

12 December 2020

Pharmacologic treatment of acute and chronic stress following trauma: 2006.

1 reference

12 December 2020

Identifiers

DOI

10.1038/MP.2015.180

1 reference

8 February 2018

1 reference

8 February 2018